In this second part of his interview, Professor David F Chang discusses his recent study which was presented at AAO 2018 – “Endophthalmitis Reduction with Intracameral Moxifloxacin After Posterior Capsule Rupture”. This 6-year retrospective study involving more than 1,540,000 consecutive cases of cataract surgery, half of which had intracameral moxifloxacin, which lowered the infection rate from 7/10,000 to 2/10,000. They also investigated the effect of posterior capsule rupture with and without intracameral moxifloxacin and found that the use of intracameral antibiotic was very effective. He then touches on the effect of climate change regulations on the updated guidelines for the cleaning, sterilization and reuse of ophthalmic tools.
1. Tell us about your recent study: “Endophthalmitis Reduction with Intracameral Moxifloxacin After Posterior Capsule Rupture” (0:11)
2. Using fewer resources is of increasing concern in the light of evidence of climate change. How is this addressed in the new guidelines? (2:10)
Speaker disclosures: David Chang has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Refractive Surgery
Gregory Parkhurst, AAO 2022: Advice for transitioning to implantable collamer lens
In this touchOPHTHALMOLOGY interview about his AAO 2022 presentation, Dr Gregory Parkhurst (Parkhurst NuVision, San Antonio, TX, US) talked to about the best practices for helping patients when they considering implantable collamer lens and provides some insightful suggestion to consulting physicians. ‘I Can’t Have LASIK … Now What? Transitioning to ICL surgery’ was presented at […]
Gregory Parkhurst, AAO 2022: I can’t have LASIK … Now what? Transitioning to implantable collamer lens
In this touchOPHTHALMOLOGY interview, Dr Gregory Parkhurst (Parkhurst NuVision, San Antonio, TX, US) discusses his AAO 2022 presentation about transitioning patients from LASIK eye surgery to implantable collamer lens. ‘I Can’t Have LASIK … Now What? Transitioning to ICL’ was presented at the annual American Academy of Ophthalmology (AAO) meeting, 30 September – 3 October […]
Manuel Vidal Sanz, European Association for Vision and Eye Research: Presidential Update 2022 Part 2
The European Association for Vision and Eye Research (EVER) is the leading ophthalmological research association in Europe, which covers all areas of ophthalmology and the visual sciences. One of the main activities of EVER is the organizing of a high-quality research meeting every year at a location chosen for its access and congress facilities. EVER […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!